Intuitive Surgical (NASDAQ:ISRG) PT Raised to $475.00

Intuitive Surgical (NASDAQ:ISRG) had its price target lifted by Stifel Nicolaus from $430.00 to $475.00 in a research note released on Friday, Benzinga reports. They currently have a buy rating on the medical equipment provider’s stock.

Several other equities analysts have also recently commented on ISRG. Truist Financial boosted their target price on Intuitive Surgical from $450.00 to $515.00 and gave the stock a buy rating in a research report on Tuesday, July 16th. Piper Sandler boosted their target price on Intuitive Surgical from $490.00 to $495.00 and gave the stock an overweight rating in a research report on Friday. Citigroup upped their price objective on Intuitive Surgical from $462.00 to $512.00 and gave the stock a buy rating in a report on Wednesday, July 10th. Jefferies Financial Group upped their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the stock a hold rating in a report on Friday, April 19th. Finally, BTIG Research upped their price objective on Intuitive Surgical from $451.00 to $459.00 and gave the stock a buy rating in a report on Monday, July 15th. Six analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of Moderate Buy and an average target price of $438.74.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $461.12 on Friday. The stock has a market cap of $163.56 billion, a PE ratio of 83.23, a price-to-earnings-growth ratio of 5.87 and a beta of 1.39. Intuitive Surgical has a fifty-two week low of $254.85 and a fifty-two week high of $468.78. The stock has a fifty day moving average of $423.65 and a 200-day moving average of $395.69.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.40% and a net margin of 27.65%. The business had revenue of $2.01 billion during the quarter, compared to analysts’ expectations of $1.97 billion. During the same period in the previous year, the business earned $1.18 earnings per share. The firm’s revenue was up 14.5% on a year-over-year basis. On average, sell-side analysts predict that Intuitive Surgical will post 4.8 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total transaction of $589,484.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Intuitive Surgical news, EVP Robert Desantis sold 239 shares of the company’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $416.60, for a total transaction of $99,567.40. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,293,799.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $421.06, for a total value of $589,484.00. The disclosure for this sale can be found here. Insiders sold 10,638 shares of company stock valued at $4,214,441 in the last 90 days. Insiders own 0.90% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in shares of Intuitive Surgical by 1.6% during the 1st quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after acquiring an additional 493,126 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in shares of Intuitive Surgical by 1.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,973,266 shares of the medical equipment provider’s stock worth $5,726,102,000 after acquiring an additional 272,741 shares during the period. Capital World Investors grew its holdings in shares of Intuitive Surgical by 1.0% during the 1st quarter. Capital World Investors now owns 7,284,269 shares of the medical equipment provider’s stock worth $2,907,079,000 after acquiring an additional 73,634 shares during the period. Edgewood Management LLC grew its stake in shares of Intuitive Surgical by 7.9% in the 4th quarter. Edgewood Management LLC now owns 5,131,066 shares of the medical equipment provider’s stock worth $1,731,016,000 after buying an additional 374,667 shares during the last quarter. Finally, Fisher Asset Management LLC grew its stake in shares of Intuitive Surgical by 2.0% in the 4th quarter. Fisher Asset Management LLC now owns 4,494,373 shares of the medical equipment provider’s stock worth $1,516,222,000 after buying an additional 88,977 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.